摘要
新近研究认为促红细胞生成素是一作用广泛的细胞保护剂,体内许多器官和组织包括心脏都表达促红细胞生成素及其受体,它可以减轻缺血缺氧时心肌细胞的损伤,减少心肌细胞的凋亡和促进新生血管生成,从而使其可能成为心血管疾病的治疗方法。
Recent studies have demonstrated that erythropbietin is a broad cytoprotective agent. Many organs and tissues including heart express erythropoietin and its receptor. When myocardial tissue is subjected to hypoxia/ ischemia stress,it can mitigate cell damage,reduce apoptosis and promote angiogenesis. As a result,erythropoietin has been identified as a possible candidate in the therapeutic strategies for cardiovascular diseases.
出处
《心血管病学进展》
CAS
2006年第1期41-44,共4页
Advances in Cardiovascular Diseases
